Back

Natriuretic peptide guided therapy - Dead or alive?

28 May 2018 (16:30 - 16:52)
Organised by:
Congress Presentation Part of: Biomarkers - Future directions Biomarkers HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor G Michael Felker

Duke University Medical Center, Durham (United States of America)

3 More presentations in this session

Presentation thumbnail
High sensitivity troponins
Professor C. Mueller (Basel, CH)
Slides Video
Presentation thumbnail
Novel biomarkers
Professor R. De Boer (Rotterdam, NL)
Slides Video
Presentation thumbnail
My clinical practice now and in 10 years
Professor A. Maisel (San Diego, US)
Video

Access the full session

Session thumbnail
Biomarkers - Future directions

The Event

Event poster

Heart Failure 2018

28 May 2018 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Clinical effects and safety of NT-proBNP-guided therapy in patients hospitalized for acute decompensated heart failure.
29 June 2021
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025
thumbnail
Congress Presentation
Natriuretic peptides and D-dimers.
29 August 2022
thumbnail
Congress Presentation
Comparison of four novel biomarkers alongside NT-proBNP for risk assessment of heart failure or death within 1 year from admission with acute dyspnoea
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources